MUHAMAD NOOR ALFARIZAL KAMARUDIN
Muhamad Noor Alfarizal Kamarudin is a lecturer at Jeffrey Cheah School of Medicine and Health Sciences, Monash University Malaysia. His research particular interest is to identify and develop a diagnostic and therapeutic approach to human gliomas. He completed his Bachelor's Degree (Biochemistry, Hons) from the University of Malaya (UM). He pursued his Master's studies, which he successfully converted into a doctorate program (UM, 2012). Upon completing his Ph.D. (2016), he obtained a postdoctoral researcher position under a three-way collaboration between UM, Taibah University of Medina, and Lincoln College University on Glioblastoma before joining BRIMS, JCSMHS in October 2017.
Dr. Alfa's primary research aspiration is to develop novel therapeutic targets in human glioma management that will tackle tumor cell motility, chemoresistant, and tumor recurrence, ultimately improving the prognosis among patients with different tumor statuses backgrounds. His cardinal focus is on targeting multimodal mechanistic pathways using molecules such as natural products, neuropeptides, and noncoding RNAs. Additionally, his research team focuses on the alternative neuroendocrine system since gender disparity is seen in human gliomas. He envisions human glioma management's bright future through neoadjuvant potentiality in improving currently established therapy that enhances patients' prognoses while being cost-effective with marginal side effects that would lead to more affordable treatment of gliomas.
He has been involved in obtaining various research grants such as the FRGS grant 2019, BRIMS-JCSMHS collaboration grants (2020), High Impact Research (HIR) UM, Fundamental Research Grant Scheme (MoHE – Best FRGS Project Award 2014), and University Malaya Research Grant (UMRG). He is also an active reviewer for several journals such as the Journal of Experimental & Clinical Cancer Research, Scientific Reports, Scientific Reports, Biomedicine & Pharmacotherapy, Frontiers in Pharmacology, Oncotarget and Therapy, Molecular and Cellular Biochemistry, Journal of Ethnopharmacology, Cancer Management and Research and Journal of Functional Food.
Abstracts this author is presenting: